Effexor XR

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

89 API Suppliers, 40 USDMF, 46 CEP/COS, 4 JDMF, 24 EU WC, 5 KDMF, 19 NDC API, 32 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

11 Drugs in Development

11 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

415 FDF Dossiers, 183 FDA Orange Book, 153 Europe, 46 Canada, 10 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - EQ 150MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 75MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 225MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 13 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 10 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 4 Kirsch Pharma, 1 Panvo Organics, 4 ACG Worldwide, 7 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 39 BASF, 2 CD Formulation, 2 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 9 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 25 Roquette, 17 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

80 Fillers, Diluents & Binders, 74 Coating Systems & Additives, 46 Disintegrants & Superdisintegrants, 46 Controlled & Modified Release, 44 Direct Compression, 39 Solubilizers, 38 Granulation, 34 Thickeners and Stabilizers, 33 Taste Masking, 28 Topical, 26 Film Formers & Plasticizers, 24 Lubricants & Glidants, 23 Parenteral, 21 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 11 Emulsifying Agents, 10 Surfactant & Foaming Agents, 9 Empty Capsules, 9 API Stability Enhancers, 6 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

28 News #PharmaBuzz

28 News #PharmaBuzz

GLOBAL SALES INFORMATION

39 US Medicaid Prescriptions, 29 Regulatory FDF Prices

MARKET PLACE

12 APIs, 1 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

FILTER :

filter Order Code Reset all filters

2 All

01 1Y0000587

02 1Y0000588

filter CAS Number Reset all filters

filter Reference Standard Reset all filters

Reset Filter

Price Info

Product Main Page

01

EDQM, Council of Europe

Venlafaxine hydrochloride

SCOPE Summit

Not Confirmed

02

EDQM, Council of Europe

Venlafaxine for system suitability

SCOPE Summit

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Effexor XR

Effexor XR

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

89 API Suppliers

40 USDMF

46 CEP/COS

4 JDMF

24 EU WC

5 KDMF

19 NDC API

32 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

11 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

415 FDF Dossiers

183 FDA Orange Book

153 Europe

46 Canada

10 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - EQ 150MG BASE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

CAPSULE, EXTENDED RELEASE;ORAL - EQ 75MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 225MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 37.5MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem

13 Evonik

2 Rochem International Inc

20 SPI Pharma

1 Pharm-RX Chemical

10 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

10 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

4 Kirsch Pharma

1 Panvo Organics

4 ACG Worldwide

7 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

39 BASF

2 CD Formulation

2 Clariant

16 Corel Pharma Chem

7 DFE Pharma

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

9 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

25 Roquette

17 Seppic

CAPSULE, EXTENDED RELEASE;ORAL - EQ 100MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons